Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00459823
Status:
SUSPENDED
Last Update Posted:
2009-03-24
First Post:
2007-04-11
Brief Title:
A Dose Escalation Study of E7107 Administered IV Bolus on Days 1 8 and 15 Every 28 Days to Patients With Solid Tumours
Sponsor:
Eisai Limited
Organization:
Eisai Inc
Study Overview
Official Title:
A Phase I Open-Label Single-Arm Dose Escalation Study of E7107 Administered IV Bolus on Days 1 8 and 15 Every 28 Days to Patients With Solid Tumours
Status:
SUSPENDED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Two-centre open-label non-randomized dose-finding phase I study to determine the MTD of E7107 administered by intravenous infusion as a 2-5 minutes bolus on days 1 8 and 15 every 28 days in patients with solid tumors for whom therapy of proven efficacy does not exist or is not longer effective
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None